Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kymera Therapeutics Inc.

    NASDAQ: KYMR · Real-Time Price · USD
    42.09
    0.54 (1.30%)
    At close: Aug 15, 2025, 12:49 PM

    Kymera Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 47.07M 78.59M 46.83M 72.83M
    Cost of Revenue
    		 n/a n/a 2.98M 2.4M
    Gross Profit
    		 47.07M 78.59M 43.85M 70.44M
    Operating Income
    		 -261.63M -165.53M -161.26M -100.53M
    Interest Income
    		 38.03M 18.76M 6.62M 488K
    Pretax Income
    		 -223.86M -146.96M -154.81M -100.22M
    Net Income
    		 -223.86M -146.96M -151.83M -98M
    Selling & General & Admin
    		 63.53M 55.04M 43.83M 36.34M
    Research & Development
    		 240.25M 189.08M 164.25M 137.02M
    Other Expenses
    		 4.92M n/a n/a n/a
    Operating Expenses
    		 308.71M 244.12M 208.08M 173.36M
    Interest Expense
    		 249K 196K 176K 175K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 308.71M 244.12M 208.08M 173.36M
    Income Tax Expense
    		 n/a n/a -2.98M -2.22M
    Shares Outstanding (Basic)
    		 75.04M 58.37M 53.93M 47.99M
    Shares Outstanding (Diluted)
    		 75.04M 58.37M 53.93M 47.99M
    EPS (Basic)
    		 -2.98 -2.52 -2.82 -2.04
    EPS (Diluted)
    		 -2.98 -2.52 -2.82 -2.04
    EBITDA
    		 -216.24M -143.2M -151.66M -97.64M
    EBIT
    		 -223.61M -146.77M -154.63M -100.04M
    Depreciation & Amortization
    		 7.37M 3.56M 2.98M 2.4M

    Add to Watchlist